0 Comments
0 Shares
43 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Anti‑inflammatory eye drugs: the $10B workhorse of ophthalmologyWhether it's uveitis, post‑surgery inflammation, or allergic conjunctivitis, anti‑inflammatory drugs are the go‑to. The ophthalmic drugs market research shows that anti‑inflammatories hold the largest share, driven by corticosteroid eye drops (prednisolone, dexamethasone) and NSAIDs (ketorolac, bromfenac). They're cheap, effective, and widely available. But long‑term steroid use can...0 Comments 0 Shares 88 Views 0 Reviews
-
Glaucoma: the silent thief of sight — and the drugs that stop itGlaucoma has no early symptoms — it quietly damages your optic nerve until you notice vision loss. That's why treatment is lifelong. The UK ophthalmic drugs market research shows that antiglaucoma drugs are the fastest‑growing segment, with a CAGR above 6%. Why? Because the UK has an aging population, and screening programmes are catching more cases early. What's in the...0 Comments 0 Shares 81 Views 0 Reviews